Evidence and practice of Doppler ultrasound in pregnancy

 
Gynecology, New, Obstetrics, Prof. Basky Thilaganathan, Members only, Customer Testimonial, HERA Z20, HERA Z20, HERA Z20
Gynecology, New, Obstetrics, Prof. Basky Thilaganathan, Members only, Customer Testimonial, HERA Z20, HERA Z20, HERA Z20

Gynecology, New, Obstetrics, Prof. Basky Thilaganathan, Members only, Customer Testimonial, HERA Z20, HERA Z20, HERA Z20

In this webinar, Prof. Basky Thilaganathan presents clinical insights on the use of Doppler ultrasound in pregnancy, focusing on its role in identifying placental dysfunction. He states that placental disease affects approximately 1 in 5 pregnancies and is a major cause of fetal growth restriction, stillbirth, and preeclampsia.

The session begins by contrasting placental causes of poor outcomes with structural and chromosomal abnormalities, which account for only 4–5% of cases. Prof. Thilaganathan critiques current antenatal screening methods based on maternal characteristics, describing them as ineffective and outdated.

He introduces a model of placental efficiency to explain how Doppler ultrasound can detect dysfunction. The key focus is on replacing traditional checklist-based screening with algorithm-based risk prediction that incorporates Doppler indices.

The webinar covers several clinical applications of Doppler:

  • Uterine artery Doppler in the first trimester to assess preeclampsia risk
  • Umbilical artery and middle cerebral artery (MCA) Doppler for monitoring fetal response to placental insufficiency
  • Ductus venosus Doppler in early-onset fetal growth restriction to assess cardiovascular adaptation
  • Cerebroplacental ratio (CPR) in the third trimester to evaluate late-onset placental dysfunction

Prof. Thilaganathan discusses major trials such as ASPRE and TRUFFLE, which support the use of Doppler combined with biomarkers and computerized CTG to improve pregnancy outcomes and guide timing of delivery, especially before 32 weeks.

He concludes by emphasizing that Doppler ultrasound provides valuable real-time insight into placental function and fetal well-being and should be integrated into routine antenatal care.

ㆍ The contents of the webinar should not be recorded or redistributed without the consent of the speakers and Samsung.
ㆍ The products, features, and options presented may not be approved, cleared, or commercially available in all jurisdictions. Please contact your local representative for specific product availability in your region.
ㆍ This content is intended for healthcare professionals only. The information presented is for educational purposes and should not be considered medical advice.
ㆍ The clinical results and patient outcomes presented may not be typical and can vary depending on multiple factors including patient condition, treatment technique, and healthcare setting.
ㆍ While we strive to provide accurate and up-to-date information, Samsung makes no warranties regarding the completeness, reliability, or accuracy of the content presented.

Featured, Gynecology, New, Obstetrics, Prof. Basky Thilaganathan, Associated member, Webinar, HERA Z20, HERA Z20, HERA Z20, HERA Z20
Featured, Gynecology, New, Obstetrics, Prof. Basky Thilaganathan, Associated member, Webinar, HERA Z20, HERA Z20, HERA Z20, HERA Z20
Saved

Share

Prof. Basky Thilaganathan

Webinar

Associated member

Applications
Gynecology Obstetrics

Products & Solutions

HERA Z20

Features

Back to list

What are you looking for?

Sign in Required!

Please sign in or sign up to access member-only content.

Enter your Serial Number

Access various content with simple product registration.

Registration unavailable

Sorry, we can not verify your serial number.
Please use a correct serial number.

Product Registered!

Your product has been successfully registered!

Done
Logout Check Icon
You Successfully log out!
Thank you for visiting theSUITE.
Can not Access

You are already signed in

Cannot sign in

Please enter your email address and password correctly